Adis International Limited

© SpringerAdis, the Australasian Drug Information Service, was acquired by Springer from Wolters Kluwer in late 2011.

The company was founded in New Zealand in the late 1960s by a hospital pharmacist who identified a need for independent evaluations of drug compounds. This led to the introduction of a suite of first-in-class drug review journals, including the globally recognised Drugs, which remains to this day a leading title in drug evaluation.

In addition to its core area of clinical pharmacotherapy, the Adis portfolio of journals and newsletters covers pharmacovigilance, health economics and outcomes research, biotechnology and personalized medicine, and specialized therapy areas. Adis also publishes three databases covering clinical trials, drug development and adverse drug reactions, further drawing upon its expertise in disseminating drug information.

Now one of Springer’s global brands with offices throughout the world and over 200 employees, Adis has maintained its roots in New Zealand with the editorial team based in Auckland.

© SpringerAdis International Limited

5 The Warehouse Way
New Zealand


tel: + 64 9 477 0700
fax: + 64 9 484 0094

Our products

Springer ADIS Argentina S.A., Buenos Aires

Avenida Santa Fé, 3711, 1A
1425 - Capital Federal Buenos Aires

View Adis International Limited in a larger map